scholarly article | Q13442814 |
P50 | author | Marja-Riitta Taskinen | Q18246437 |
P2093 | author name string | Anja Schweizer | |
James E Foley | |||
Juha Vakkilainen | |||
Niina Mero | |||
P2860 | cites work | Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels | Q34386174 |
Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance | Q34399523 | ||
Analysis of serial measurements in medical research | Q35167613 | ||
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma | Q40341530 | ||
Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease | Q40677577 | ||
Repeated measurements and multiple comparisons in cardiovascular research | Q40748707 | ||
Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease | Q40810473 | ||
Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). | Q41140104 | ||
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes | Q43618975 | ||
Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study | Q44049495 | ||
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction | Q44144342 | ||
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 | ||
Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. | Q51573174 | ||
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. | Q51574301 | ||
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance | Q51590571 | ||
Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects | Q71858705 | ||
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM | Q73250750 | ||
Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in Type 2 diabetes mellitus | Q73718604 | ||
Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group | Q74313811 | ||
P433 | issue | 6 | |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 484-490 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
P1476 | title | Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes | |
P478 | volume | 18 |
Q44744484 | A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes |
Q89586580 | Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study |
Q51475245 | Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes. |
Q73210876 | Current literature in diabetes |
Q35139885 | Diabetic dyslipidaemia: from basic research to clinical practice. |
Q40535355 | Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes. |
Q51381989 | Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. |
Q44236773 | Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes |
Q46368028 | Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test |
Q26862823 | Impact of postprandial glycaemia on health and prevention of disease |
Q47318058 | Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease |
Q36349994 | Low-density lipoprotein size and cardiovascular risk assessment. |
Q36343495 | New insight into the pathophysiology of lipid abnormalities in type 2 diabetes |
Q45277368 | No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes |
Q35521022 | Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes |
Q39101008 | Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes |
Q44980056 | Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism |
Q46044954 | Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitus |
Q46905943 | The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients. |
Q51495360 | Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. |